Foster G. serves as the Vice President of Clinical Development and Program Development Lead at BBOT since September 2022, while also holding the position of Vice President of Business Development and Operations at BridgeBio since February 2021. With extensive experience in oncology, Foster has worked as a Consultant in Translational Medicine at Inspirna, Inc. from January 2013 to February 2025, contributing to pivotal oncology trials and clinical operations. Previous roles include Vice President of Drug Development and Strategy and Vice President of Preclinical Development at Inspirna, where responsibilities included early development strategy and translational science support. Foster's career also includes consultancy roles at Easton Associates and Navigant, along with a Postdoctoral Fellowship at NYU School of Medicine. Educational qualifications include a Ph.D. in Molecular & Cell Biology from the University of California, Berkeley, and a Master of Public Health from Columbia University Mailman School of Public Health.
This person is not in any teams
This person is not in any offices
BridgeBio Oncology Therapeutics (BBOT)
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.